HEADER TRANSCRIPTION 07-AUG-23 8TQD TITLE NF-KAPPA-B1 BOUND WITH A COVALENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR FACTOR NF-KAPPA-B P105 SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NFKB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS TRANSCRIPTION FACTOR, DNA BINDING PROTEIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR B.J.HILBERT REVDAT 3 22-MAY-24 8TQD 1 JRNL REVDAT 2 08-MAY-24 8TQD 1 JRNL REVDAT 1 24-APR-24 8TQD 0 JRNL AUTH M.TAKAHASHI,H.B.CHONG,S.ZHANG,T.Y.YANG,M.J.LAZAROV,S.HARRY, JRNL AUTH 2 M.MAYNARD,B.HILBERT,R.D.WHITE,H.E.MURREY,C.C.TSOU, JRNL AUTH 3 K.VORDERMARK,J.ASSAAD,M.GOHAR,B.R.DURR,M.RICHTER,H.PATEL, JRNL AUTH 4 G.KRYUKOV,N.BROOIJMANS,A.S.O.ALGHALI,K.RUBIO,A.VILLANUEVA, JRNL AUTH 5 J.ZHANG,M.GE,F.MAKRAM,H.GRIESSHABER,D.HARRISON,A.S.KOGLIN, JRNL AUTH 6 S.OJEDA,B.KARAKYRIAKOU,A.HEALY,G.POPOOLA,I.RACHMIN, JRNL AUTH 7 N.KHANDELWAL,J.R.NEIL,P.C.TIEN,N.CHEN,T.HOSP, JRNL AUTH 8 S.VAN DEN OUWELAND,T.HARA,L.BUSSEMA,R.DONG,L.SHI, JRNL AUTH 9 M.Q.RASMUSSEN,A.C.DOMINGUES,A.LAWLESS,J.FANG,S.YODA, JRNL AUTH10 L.P.NGUYEN,S.M.REEVES,F.N.WAKEFIELD,A.ACKER,S.E.CLARK, JRNL AUTH11 T.DUBASH,J.KASTANOS,E.OH,D.E.FISHER,S.MAHESWARAN,D.A.HABER, JRNL AUTH12 G.M.BOLAND,M.SADE-FELDMAN,R.W.JENKINS,A.N.HATA,N.M.BARDEESY, JRNL AUTH13 M.L.SUVA,B.R.MARTIN,B.B.LIAU,C.J.OTT,M.N.RIVERA, JRNL AUTH14 M.S.LAWRENCE,L.BAR-PELED JRNL TITL DRUGMAP: A QUANTITATIVE PAN-CANCER ANALYSIS OF CYSTEINE JRNL TITL 2 LIGANDABILITY. JRNL REF CELL V. 187 2536 2024 JRNL REFN ISSN 1097-4172 JRNL PMID 38653237 JRNL DOI 10.1016/J.CELL.2024.03.027 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0415 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 16462 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 802 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1206 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.4310 REMARK 3 BIN FREE R VALUE SET COUNT : 63 REMARK 3 BIN FREE R VALUE : 0.7460 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1557 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.53000 REMARK 3 B22 (A**2) : 0.53000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.033 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.032 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.272 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1649 ; 0.004 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 1593 ; 0.002 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2232 ; 1.165 ; 1.703 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3675 ; 0.413 ; 1.607 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 202 ; 7.447 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 11 ; 3.799 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 289 ;18.160 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 243 ; 0.056 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1921 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 370 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 808 ; 2.578 ; 4.689 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 808 ; 2.578 ; 4.689 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1010 ; 3.926 ; 8.425 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1011 ; 3.925 ; 8.426 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 841 ; 2.684 ; 5.118 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 842 ; 2.683 ; 5.119 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1223 ; 4.508 ; 9.257 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1803 ; 7.192 ;49.620 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1784 ; 7.175 ;49.360 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 40 A 301 REMARK 3 ORIGIN FOR THE GROUP (A): 12.9663 6.7550 -0.7372 REMARK 3 T TENSOR REMARK 3 T11: 0.0122 T22: 0.0469 REMARK 3 T33: 0.0096 T12: -0.0202 REMARK 3 T13: -0.0046 T23: 0.0122 REMARK 3 L TENSOR REMARK 3 L11: 0.2617 L22: 0.2790 REMARK 3 L33: 0.5093 L12: -0.0632 REMARK 3 L13: 0.0546 L23: -0.1030 REMARK 3 S TENSOR REMARK 3 S11: -0.0266 S12: -0.0083 S13: -0.0017 REMARK 3 S21: 0.0024 S22: 0.0008 S23: -0.0408 REMARK 3 S31: -0.0375 S32: 0.0605 S33: 0.0259 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8TQD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1000276388. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL45XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17269 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 49.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 10.30 REMARK 200 R MERGE FOR SHELL (I) : 1.06000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRATE PH5.0, 20%W/V PEG 6000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.95000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 47.90000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 39 REMARK 465 ALA A 180 REMARK 465 GLU A 181 REMARK 465 GLY A 182 REMARK 465 GLY A 183 REMARK 465 GLY A 184 REMARK 465 PRO A 245 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA A 155 O HOH A 401 1.67 REMARK 500 SG CYS A 61 C10 JMR A 301 2.07 REMARK 500 N GLU A 159 O HOH A 401 2.09 REMARK 500 O LEU A 170 O HOH A 402 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 147 -34.83 101.34 REMARK 500 VAL A 171 -63.67 -108.20 REMARK 500 ASP A 237 151.40 -49.65 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TQD A 40 245 UNP P19838 NFKB1_HUMAN 40 245 SEQADV 8TQD GLY A 39 UNP P19838 EXPRESSION TAG SEQRES 1 A 207 GLY ASP GLY PRO TYR LEU GLN ILE LEU GLU GLN PRO LYS SEQRES 2 A 207 GLN ARG GLY PHE ARG PHE ARG TYR VAL CYS GLU GLY PRO SEQRES 3 A 207 SER HIS GLY GLY LEU PRO GLY ALA SER SER GLU LYS ASN SEQRES 4 A 207 LYS LYS SER TYR PRO GLN VAL LYS ILE CYS ASN TYR VAL SEQRES 5 A 207 GLY PRO ALA LYS VAL ILE VAL GLN LEU VAL THR ASN GLY SEQRES 6 A 207 LYS ASN ILE HIS LEU HIS ALA HIS SER LEU VAL GLY LYS SEQRES 7 A 207 HIS CYS GLU ASP GLY ILE CYS THR VAL THR ALA GLY PRO SEQRES 8 A 207 LYS ASP MET VAL VAL GLY PHE ALA ASN LEU GLY ILE LEU SEQRES 9 A 207 HIS VAL THR LYS LYS LYS VAL PHE GLU THR LEU GLU ALA SEQRES 10 A 207 ARG MET THR GLU ALA CYS ILE ARG GLY TYR ASN PRO GLY SEQRES 11 A 207 LEU LEU VAL HIS PRO ASP LEU ALA TYR LEU GLN ALA GLU SEQRES 12 A 207 GLY GLY GLY ASP ARG GLN LEU GLY ASP ARG GLU LYS GLU SEQRES 13 A 207 LEU ILE ARG GLN ALA ALA LEU GLN GLN THR LYS GLU MET SEQRES 14 A 207 ASP LEU SER VAL VAL ARG LEU MET PHE THR ALA PHE LEU SEQRES 15 A 207 PRO ASP SER THR GLY SER PHE THR ARG ARG LEU GLU PRO SEQRES 16 A 207 VAL VAL SER ASP ALA ILE TYR ASP SER LYS ALA PRO HET JMR A 301 40 HETNAM JMR 1-(2-BROMO-4-CHLOROPHENYL)-N-{(3S)-1-[(E)- HETNAM 2 JMR IMINOMETHYL]PYRROLIDIN-3-YL}METHANESULFONAMIDE FORMUL 2 JMR C12 H15 BR CL N3 O2 S FORMUL 3 HOH *99(H2 O) HELIX 1 AA1 TYR A 59 GLY A 63 5 5 HELIX 2 AA2 LYS A 148 GLY A 164 1 17 HELIX 3 AA3 ASN A 166 VAL A 171 1 6 HELIX 4 AA4 HIS A 172 ALA A 176 5 5 HELIX 5 AA5 GLY A 189 MET A 207 1 19 SHEET 1 AA1 3 TYR A 43 GLU A 48 0 SHEET 2 AA1 3 GLN A 83 CYS A 87 -1 O LYS A 85 N GLN A 45 SHEET 3 AA1 3 VAL A 133 GLY A 135 -1 O VAL A 134 N VAL A 84 SHEET 1 AA2 5 CYS A 118 GLU A 119 0 SHEET 2 AA2 5 ILE A 122 ALA A 127 -1 O ILE A 122 N GLU A 119 SHEET 3 AA2 5 ALA A 93 VAL A 100 -1 N VAL A 95 O VAL A 125 SHEET 4 AA2 5 VAL A 211 PRO A 221 -1 O PHE A 219 N LYS A 94 SHEET 5 AA2 5 PHE A 227 ARG A 230 -1 O ARG A 229 N LEU A 220 SHEET 1 AA3 5 CYS A 118 GLU A 119 0 SHEET 2 AA3 5 ILE A 122 ALA A 127 -1 O ILE A 122 N GLU A 119 SHEET 3 AA3 5 ALA A 93 VAL A 100 -1 N VAL A 95 O VAL A 125 SHEET 4 AA3 5 VAL A 211 PRO A 221 -1 O PHE A 219 N LYS A 94 SHEET 5 AA3 5 VAL A 234 TYR A 240 -1 O SER A 236 N LEU A 214 SHEET 1 AA4 2 SER A 112 VAL A 114 0 SHEET 2 AA4 2 GLY A 140 LEU A 142 -1 O LEU A 142 N SER A 112 LINK SG CYS A 61 C10AJMR A 301 1555 1555 1.68 CISPEP 1 GLY A 128 PRO A 129 0 6.07 CRYST1 57.210 57.210 71.850 90.00 90.00 120.00 P 31 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017479 0.010092 0.000000 0.00000 SCALE2 0.000000 0.020184 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013918 0.00000